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The bacterial cell wall is fortified by the biopolymer murein (pep- 
tidoglycan), a meshwork of glycan strands that are cross-linked by 
peptide bridges. The murein layer forms a covalently closed string- 
bag-like structure, called sacculus. Thus, p w t h  of a bacterium de- 
pends on the simultaneous enlargement of its murein sacculus. In or- 
der to enlarge the murein netting the concerted activities of enzymes 
cleaving meshes and e n m e s  inserting new subunits, that is murein 
hydrolases and synthases, are needed. Most important however, the 
murein hydrolases must not act separately to avoid dissolution of 
the stress-bearing sacculus and hence bacteriolysis. Recent experi- 
mental results indicate that one way of controlling the potentially 
autolytic murein hydrolases seems to be their integration within a 
multienzyme complex, a murein synthesizing machmery combining 
both hydrolases and syntheses. Accordingly, any block in the sup- 
ply of activated murein precursors will result in an idling of the 
machinery with the murein hydrolases degradmg the murein. Bac- 
teriolysis is indeed the hallmark of most murein synthesis inhibitors. 
The conception of a murein synthesizing machinery suggests a novel 
target for antibiotics. Compounds interfering with the assembly of a 
functional machinery are expected to block further enlargement of 
the sacculus and moreover are likely to induce autolysis due to the 
missing control of the hydrolases by the complex. 
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DNA gyrase w&originally identified as a target of 4-quinolones 
&om resistance mutations in W A  and later gyB,  the genes encoding 
the two enzyme subunits, GyrA and GyrB, in Escheriskia coli. The 
clustering of resistance mutations within domains of GyrA and GyrB 
and the reduction in binding of quinolones to resistant gyrase-DNA 
complexes indicated that resistance was mediated by enzyme changes 
that reduced drug binding af2inity Recent models based on the crys- 
tal structure of the yeast topoisomerase I1 homolog localize altered 
amino acids of mutant GyrA near the site of DNA strand breakage 
and suggest a means for drug binding to antagonize enzyme func- 
tion and trap DNA deavage intermediates. Altered amino acids of 
mutant GyrB, however, are distantly placed from those in GyrA and 
from the jaws of the proposed clamps involved in DNA strand pas- 
sage, leaving unclear how these changes might effect resistance. More 
recently topoisomerase IV, a homolog of DNA gyrase encoded by 
the parC and parE genes, has been identified as a quinolone target. 
Resistance mutations in parC and parE in regions sunilar to those 
of gyrA and ~ y r B  have been found. parC and parE mutations in E.  
coli, however, cause resistance to ciprofloxacin only in the presence 
of resistant gyrase, indcating that topoisomerase IV is a secondary 
target of ciprofloxacin. In S. auras and Streptococcus pneumoniae, in 
contrast, parC mutations alone are sufficient to cause low-level resis- 
tance, and gyrA mutations cause ciprofloxacin resistance only in the 
presence of resistant topoisomerase rV, indicating that topoisomerase 
IV is the principal target. In recent work by others the sensitivity 
of the enzymes purified from E .  coli and S. aureus indmted that 
species-specific Merences in the primary targets of ciprofloxacin are 
likely determined by the enzyme with the most drug sensitivity. 
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Switzerland 
Methidm resistance in Staphyloroccus aureus is due to the acquisition 
of an additional, low &ty penidin-bindmg protein, PBPZ', that 
adds to the resident four PBPs of the cells. This foreign PBPZ' needs 
specific conditions for optimal expression of methicillin resistance. . 
Any changes in the balance or chemistry of peptidoglycan precursor 
formation has usually negative effects on the ability of PBPZ' to 
confer methidm resistance. The most important role plays thereby 
the characteristic pentaglycine side-chain (Glyl-5) that is attached to 
the peptidoglycan stem-peptide. It functions as acceptor in the PBP 
catalysed transpeptidase reaction. Its length and flexibihty allows a 
high cross-linking between the peptidoglycan strands that form the 
murein sacculus. Shortening of rhis side-chain abolishes methicillin 
resistance. The proteins involved in the addition of Gly2-Gly3 and 
of Gly4-Gly5 have been identified as F e d  and F e d ,  respectively. 
They are encoded by the f d B  operon. Although f e d B  Null 
mutants are still viable under laboratory conditions, their growth is 
strongly impaired. They are hypersusceptible to a l l  &lactams as well 
as to aIl other classes of antibiotics. F e d  and FemB are therefore 
potential targets for new antibacterial agents that may restore the 
efficacy of b-lactams against methicillin resistant S. aurm.  A fuaher 
promising drug-target is the not yet identified F e d ,  postulated to 
catalyse the attachment of the first glycine residue of the side-chain 
to the stem-peptide. 
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Rapid identification of pathogenic bacteria is important chcally 
because it can offer clues toward antibiotic resistance, the route of 
mfection, and have an impact on patient care. 
From more than 130 species of Enterobacteriaceae known today, 
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about 20 are commonly isolated h m  clinical material (usual species), 
the remaining being either atypical or rare species. 
Classic identification relies on manual, semi-automated or au- 
tomated phenotypic methods, which perform well (>90% correct 
identification) for the usual species. Rapid identhcation systems give 
the same efficacy in a few hours. 
Among genotypic methods of identification, amplhcation-based 
techmques applied to cultured organisms can give species-specific 
fingerprints (rDNA-RFLP, rDNA-SSCP, tRNA inter-repeat LP, 
rDNA spacer LP). These techniques are fast, automatable, and reli- 
able. DNA sequencing - albeit not routinely applicable - and bio- 
chemical sequencing coupled to fluorescent analysis of the products 
are now being developed. A new genotypic approach consists of 
microchps coated with an array of oligonucleotides, allowing rapid 
identification by the determination of pattern(s) or sequence(s) spe- 
c& for the target microorganism(s). 
Hybridization events are determined by a high resolution optics. 
The future implementation of these revolutionary methods in 
clmical bacteriology laboratories will depend on their ease, cost and 
accuracy, as well as on the concomitant development of molecular 
determination of antibiotic susceptibility and resistance. 
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EEective detection and surveillance of antimicrobial resistance re- 
quires rapid and accurate laboratory methods. Standard methods 
such as disk d&sion, agar screens, and broth or igar dilutions do 
not produce rapid results (e.g. 48 h to detect staphylococcal methi- 
cillin resistance, 24 h to detect enterococcal vancomycin resistance) 
and, in some cases, have accuracy limitations (e.g. detection of peni- 
cihn-resistant pneumococci or cephalosporin resistance in Enferobac- 
teriactae). Automated phenotypic methods and molecular detection 
of resistance genes offer two strategies for overcoming the limita- 
tions of conventional testing methods. For example, in our prelim- 
inary evaluation the automated Vitek I1 system (bioMerieux Vitek, 
Inc.) produced beta-lactam susceptibility results with S. pnewmoniae 
and Enterobncteriaceae in a average time range of 6 to 8 h. Results 
were both rapid and accurate as no false susceptibility occurred with 
penicillin- or cephalosporin-resistant pneumococci and false suscep- 
tibility to extended spectrum cephalosporins among Enferobncteriaceae 
occurred in only 0.5% of 198 resistant isolates tested. Regardless 
of these promising resultj detection of several current (e.g. methi- 
cillin-resistant staphylococci, vancomycin-resistant enterococci) and 
emerging resistances will continue to challenge the reliabdity and 
utility of phenotype-based methods. Therefore, molecular methods 
and strategies, such as those for mevl and van gene detection, are now 
used and will continue to be developed to augment, and someday 
supplant, many phenotypic methods. To optimize rapid and accurate 
detection of resistance, cooperative development of automated and 
molecular technologies wiIl continue. 
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Detection of antibiotic resistance is a major goal of the antimicrobial 
susceptibihty tests. Since no single methodology is sufficient to de- 
tect all relevant antimicrobial resistances, two non mutually exclusive 
approaches could be developped combination of methods (for in- 
stance conventional and molecular) or use of expert systems. So far, 
the latter way has been developped and several expert systems are 
available whch are mostly based on rule bases. The rule bases need 
careful choice of the antibiotics tested as phenotypic markers and use 
of susceptibility categories whch are already interpreted results based 
on local criteria. These systems only work with a given selection of 
antibiotics. The notion that bacterla strains can be grouped into 
phenotypes characterized by a global profde of susceptibility which 
results &om both intrinsic and acquired resistance traits and that raw 
results rather than susceptibility categories should be used to improve 
detection of resistance mechanisms, yielded a new concept of expert 
systems that intend to be universal. These systems rely on global phe- 
notypes of the bacteria dwtinguished by susceptibihty (for instance, 
measured by MICs) to numerous antibiotics and therefore requires 
an extensive knowledge base built h m  known MICs distributions. 
The phenotypes are characterized within each bacterial species. Bi- 
ological validation is based on comparison of the profile of measured 
MICs for a given strain with profiles in the knowledge base. It al- 
lows to detect technical errors and "impossible phenotypes". The 
determination of the phenotype allows to correct the results if it is 
necessary. The final interpretation iden  a deduced result &om the 
observed phenotype; it also produces extension for non tested an- 
tibiotics. Finally, recommendations on the most likely useful drugs 
can be added on the basis of local or universal consensus. 
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New Perspectives for Automation of 
Microbiological Methods 
J.P Gayral. bioM&eur, fiance 
The development of automated microbiology methods has grown 
in the past ten years and is influenced by technological and eco- 
nomical factors. The technological factors are multiple in the areas 
of informatics, instrumentation and molecular biology. The fast de- 
velopment of sofnvare applications, information systems, networks, 
transforms the microbiology laboratory into an information provider. 
The new instrumentation technologies: robotics, optoelectronics, 
microfabrication, systems integration, brings to the microbiology 
laboratory a true automation which may significantly change its 
whole organization. A breakthrough already occurred with the nu- 
cleic acid amplification methods; it will reach a second step with 
the availabihty of chip technology which d make possible the 
detection of genetic variabhty of several targets hrectly on a speci- 
men. The generalization of these methods might be slowed by many 
economical factors: reduction in health expenses, global managed 
care, increased regulations on hagnostic laboratories and industry, 
consolidation of laboratories and concentration of industry. In this 
environment, the laboratory organization will need to be optimized 
and procedures which combine several approaches will be devel- 
oped simple cost effective screening tests, integrated automation for 
large volume routine testing, direct molecular testing for value added 
diagnostics. The next decade should see a broader use of information 
systems and more integrated automation where molecular methods 
will take a growing part. 
